Sensex rises, Nifty ends at record high; RIL shares rally.
The Nifty had hit its third successive record high of 7,922.70 today.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
Payments banks will mainly deal in remittance services and accept deposits of up to Rs 1 lakh.
The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.
Generic drugmakers cannot be sued under state law for adverse reactions to their products.
The 30-share Sensex closed down 114 points at 28,622 and the 50-share Nifty ended down 37 points at 8,686.
Dilip Shanghvi has never tried to be everything to everybody.
Sensex gained 38.18 points or 0.15% at 25,918.95 and Nifty ended higher by 12.50 points or 0.16% at 7,739.55.
USL is already contesting a Karnataka High Court order.
Markets in green tracking firm global cues.
Ranbaxy did its maiden public issue in 1973.
Dilip Shanghvi founded Sun Pharma in 1983.
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
A majority of India's billionaires gained wealth in the last one year in spite of the stock market decline.
T N Ninan lists a few David-Goliath encounters in the Indian markets, all of which make life interesting, though difficult if you are an investor looking for the next multi-bagger.
Few top honchos of India Inc did very well in 2014.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances